MX351704B - Diagnóstico de vacuna mejorado. - Google Patents
Diagnóstico de vacuna mejorado.Info
- Publication number
- MX351704B MX351704B MX2014002170A MX2014002170A MX351704B MX 351704 B MX351704 B MX 351704B MX 2014002170 A MX2014002170 A MX 2014002170A MX 2014002170 A MX2014002170 A MX 2014002170A MX 351704 B MX351704 B MX 351704B
- Authority
- MX
- Mexico
- Prior art keywords
- improved vaccine
- diagnostics
- bvdv
- vaccine diagnostics
- animals
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56983—Viruses
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
- G01N2333/08—RNA viruses
- G01N2333/18—Togaviridae; Flaviviridae
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
- G01N2333/08—RNA viruses
- G01N2333/18—Togaviridae; Flaviviridae
- G01N2333/183—Flaviviridae, e.g. pestivirus, mucosal disease virus, bovine viral diarrhoea virus, classical swine fever virus (hog cholera virus) or border disease virus
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2469/00—Immunoassays for the detection of microorganisms
- G01N2469/20—Detection of antibodies in sample from host which are directed against antigens from microorganisms
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Virology (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Analytical Chemistry (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- Tropical Medicine & Parasitology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Medicinal Chemistry (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Wood Science & Technology (AREA)
- Biophysics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
Abstract
La presente invención se refiere a un método para detectar la presencia de un anticuerpo que se enlaza de manera específica a una proteína Ems de virus de la diarrea viral bovina (BVDV), comprendiendo dicho método las etapas de: a) incubar una muestra de suero de un animal con proteína Ems de perstivirus de antílope americano o un fragmento de la misma al que se enlazan anticuerpos que reaccionan de forma cruzada con DVDV Ems, en donde dicha muestra de suero se incuba antes o simultáneamente con la etapa b); b) añadir dicha muestra de a) a una placa de ensayo que comprende proteína BVDV Ems enlazada; y c) detectar muestra la presencia de dicho anticuerpo, en donde la detección comprende añadir un anticuerpo monoclonal específico marcado de BVDV Ems a la placa de ensayo, en donde el anticuerpo marcado se unirá a la proteína BVDV Ems unida.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161526792P | 2011-08-24 | 2011-08-24 | |
| PCT/IB2012/054092 WO2013027149A1 (en) | 2011-08-24 | 2012-08-10 | Improved vaccine diagnostics |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MX2014002170A MX2014002170A (es) | 2014-08-01 |
| MX351704B true MX351704B (es) | 2017-10-24 |
Family
ID=46970364
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2014002170A MX351704B (es) | 2011-08-24 | 2012-08-10 | Diagnóstico de vacuna mejorado. |
Country Status (26)
| Country | Link |
|---|---|
| US (1) | US9291624B2 (es) |
| EP (1) | EP2748612B1 (es) |
| JP (1) | JP6080850B2 (es) |
| KR (1) | KR101667122B1 (es) |
| CN (1) | CN103917874B (es) |
| AR (1) | AR087654A1 (es) |
| AU (1) | AU2012298229B2 (es) |
| BR (1) | BR112014004261B8 (es) |
| CA (1) | CA2846385C (es) |
| CL (1) | CL2014000434A1 (es) |
| CY (1) | CY1119873T1 (es) |
| DK (1) | DK2748612T3 (es) |
| ES (1) | ES2647764T3 (es) |
| HK (1) | HK1194814A1 (es) |
| HR (1) | HRP20171623T1 (es) |
| HU (1) | HUE034632T2 (es) |
| LT (1) | LT2748612T (es) |
| ME (1) | ME02909B (es) |
| MX (1) | MX351704B (es) |
| NO (1) | NO2746715T3 (es) |
| PL (1) | PL2748612T3 (es) |
| PT (1) | PT2748612T (es) |
| RS (1) | RS56579B1 (es) |
| SI (1) | SI2748612T1 (es) |
| UY (1) | UY34286A (es) |
| WO (1) | WO2013027149A1 (es) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201113942D0 (en) * | 2011-08-12 | 2011-09-28 | Nec Corp | Communication system |
| AU2012298229B2 (en) * | 2011-08-24 | 2015-12-10 | Zoetis Services Llc | Improved vaccine diagnostics |
| CN103197082B (zh) * | 2013-04-16 | 2015-07-15 | 深圳出入境检验检疫局动植物检验检疫技术中心 | 牛病毒性腹泻病毒抗体快速检测试纸条 |
| KR101848194B1 (ko) * | 2013-12-19 | 2018-04-11 | 인터벳 인터내셔널 비.브이. | Csfv 항체에 대한 개선된 진단 시험 |
| CN108430504A (zh) * | 2015-12-30 | 2018-08-21 | 英特维特国际股份有限公司 | 瘟病毒标记疫苗 |
| CN109136267B (zh) * | 2018-09-19 | 2023-03-31 | 天康生物股份有限公司 | BVDV Erns蛋白和抗体及筛选BVDV感染的牛的方法 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6001613A (en) | 1996-05-24 | 1999-12-14 | Board Of Regents Of University Of Nebraska | Plasmid bearing a cDNA copy of the genome of bovine viral diarrhea virus, chimeric derivatives thereof, and method of producing an infectious bovine viral diarrhea virus using said plasmid |
| US6174667B1 (en) | 1997-09-23 | 2001-01-16 | Cornell Research Foundation, Inc. | Bovine viral diarrhea virus serum antigen capture |
| EP0924298A1 (en) * | 1997-12-18 | 1999-06-23 | Stichting Instituut voor Dierhouderij en Diergezondheid (ID-DLO) | Protein expression in baculovirus vector expression systems |
| CA2297694C (en) * | 1999-02-12 | 2008-04-22 | Akzo Nobel N.V. | Antibodies and diagnostic methods for the diagnosis of pestviruses |
| EP1170367A1 (en) * | 2000-06-27 | 2002-01-09 | Bayer Ag | BVDV virus-like particles |
| CN1460857A (zh) * | 2003-06-10 | 2003-12-10 | 陈睿锋 | 牛病毒性腹泻病毒抗体间接elisa检测方法 |
| US7763460B2 (en) * | 2005-06-24 | 2010-07-27 | Focus Diagnostics, Inc. | Methods and compositions for detecting herpes simplex virus type 2 |
| AU2009323784B2 (en) | 2008-12-03 | 2013-08-15 | Zoetis Services Llc | Bovine viral diarrhea virus with a modified Erns protein |
| CN102023217A (zh) * | 2010-12-01 | 2011-04-20 | 扬州大学 | 牛病毒性腹泻病毒双抗夹心生物素-亲和素elisa检测试剂盒及使用方法 |
| AU2012298229B2 (en) * | 2011-08-24 | 2015-12-10 | Zoetis Services Llc | Improved vaccine diagnostics |
-
2012
- 2012-08-10 AU AU2012298229A patent/AU2012298229B2/en active Active
- 2012-08-10 HU HUE12768901A patent/HUE034632T2/en unknown
- 2012-08-10 PT PT127689016T patent/PT2748612T/pt unknown
- 2012-08-10 US US14/239,917 patent/US9291624B2/en active Active
- 2012-08-10 LT LTEP12768901.6T patent/LT2748612T/lt unknown
- 2012-08-10 PL PL12768901T patent/PL2748612T3/pl unknown
- 2012-08-10 ES ES12768901.6T patent/ES2647764T3/es active Active
- 2012-08-10 BR BR112014004261A patent/BR112014004261B8/pt active IP Right Grant
- 2012-08-10 ME MEP-2017-251A patent/ME02909B/me unknown
- 2012-08-10 CA CA2846385A patent/CA2846385C/en active Active
- 2012-08-10 RS RS20171180A patent/RS56579B1/sr unknown
- 2012-08-10 JP JP2014526574A patent/JP6080850B2/ja active Active
- 2012-08-10 DK DK12768901.6T patent/DK2748612T3/da active
- 2012-08-10 WO PCT/IB2012/054092 patent/WO2013027149A1/en active Application Filing
- 2012-08-10 KR KR1020147007225A patent/KR101667122B1/ko active IP Right Grant
- 2012-08-10 MX MX2014002170A patent/MX351704B/es active IP Right Grant
- 2012-08-10 CN CN201280052231.6A patent/CN103917874B/zh active Active
- 2012-08-10 SI SI201231121T patent/SI2748612T1/sl unknown
- 2012-08-10 EP EP12768901.6A patent/EP2748612B1/en active Active
- 2012-08-23 UY UY0001034286A patent/UY34286A/es active IP Right Grant
- 2012-08-23 AR ARP120103114A patent/AR087654A1/es active IP Right Grant
-
2013
- 2013-12-04 NO NO13005636A patent/NO2746715T3/no unknown
-
2014
- 2014-02-24 CL CL2014000434A patent/CL2014000434A1/es unknown
- 2014-08-07 HK HK14108091.5A patent/HK1194814A1/zh unknown
-
2017
- 2017-10-24 HR HRP20171623TT patent/HRP20171623T1/hr unknown
- 2017-11-27 CY CY20171101242T patent/CY1119873T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PH12018501602A1 (en) | Subunit immersion vaccines for fish | |
| MX2014002170A (es) | Diagnostico de vacuna mejorado. | |
| EP4282983A3 (en) | Compositions and methods for polynucleotide sequencing | |
| EA201490659A1 (ru) | Вакцины против вируса гриппа и их применения | |
| PH12014502534B1 (en) | Effective vaccination against porcine reproductive and respiratory syndrome (prrs) virus prior to weaning | |
| WO2012112489A3 (en) | Compositions and methods for the therapy and diagnosis of influenza | |
| PH12016501366A1 (en) | Novel anti-baff antibodies | |
| MX2023006416A (es) | Anticuerpos, usos y metodos. | |
| MX2016007737A (es) | Variante del virus prrs, clon de adnc del virus europeo y sus usos. | |
| MY191539A (en) | Streptococcal vaccine | |
| PH12015501378A1 (en) | Porcine parvovirus 5a, methods of use and vaccine | |
| WO2015009740A3 (en) | Anti-mucin 1 binding agents and uses thereof | |
| WO2016057683A3 (en) | Novel anti-nodal antibodies and methods of using same | |
| MY179251A (en) | Methods and compositions for recombinant dengue viruses for vaccine and diagnostic development | |
| PH12015501721A1 (en) | Porcine parvovirus 5b, methods of use and vaccine | |
| MX2019007252A (es) | Metodos y composiciones para vacunas del virus del dengue. | |
| WO2015023508A8 (en) | Methods for improving asthma symptoms using benralizumab | |
| EP3346270A4 (en) | COMPOSITION FOR THE DIAGNOSIS OF INFECTIOUS DISEASES OR INFECTIOUS COMPLICATIONS USING TRYPTOPHANYL ARNT SYNTHASE, AND METHOD FOR DETECTION OF DIAGNOSTIC MARKER | |
| PH12017501795B1 (en) | Pestivirus vaccines for congenital tremors | |
| MX350718B (es) | Vacuna de rinitis equina. | |
| WO2013151662A3 (en) | Therapies, vaccines, and predictive methods for infectious salmon anemia virus | |
| UA86068U (ru) | Экспресс-метод ранней диагностики вирусных гепатитов - метод и.а. кирющенко | |
| 周君红 | gkh | |
| WO2015048289A3 (en) | Correlates of protection against hiv-1 infection | |
| UA89175U (uk) | Протидіабетичний засіб з гіпоглікемічною дією "колоцинт-антидіабет" |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration |